US EditionDEA revokes license of wholesale drug distributor Morris & Dickson over opioid crisis failures
- Morris & Dickson Co. has lost its license to sell highly addictive painkillers after failing to flag thousands of suspicious orders during the opioid crisis.
- The DEA allowed the company to keep shipping drugs for almost four years after a judge recommended the harshest penalty.
- The company must negotiate a settlement within 90 days before the order takes effect, but the DEA considers the company's response inadequate because it failed to accept full responsibility and understand the potential harm it caused.
125 Articles
125 Articles
After long delay, DEA revokes license of drug wholesaler over opioid crisis failures
The U.S. Drug Enforcement Administration has stripped one of the nation's largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis.
After long delay, DEA revokes license of drug wholesaler over opioid crisis failures
The U.S. Drug Enforcement Administration has stripped one of the nation's largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis.
After long delay, DEA revokes license of drug wholesaler over opioid crisis failures
The U.S. Drug Enforcement Administration has stripped one of the nation's largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis.
After long delay, DEA revokes license of drug wholesaler over opioid crisis failures
The U.S. Drug Enforcement Administration has stripped one of the nation's largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis.
After long delay, DEA revokes license of drug wholesaler over opioid crisis failures
The U.S. Drug Enforcement Administration has stripped one of the nation's largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis.
After long delay, DEA revokes license of drug wholesaler over opioid crisis failures
The U.S. Drug Enforcement Administration has stripped one of the nation's largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis.
Coverage Details
Bias Distribution
- 73% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
